VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 115 filers reported holding VANDA PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.36 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $110,005 | -95.1% | 25,464 | -92.5% | 0.00% | -100.0% |
Q2 2023 | $2,223,874 | -6.6% | 337,462 | -3.8% | 0.00% | 0.0% |
Q1 2023 | $2,381,714 | -9.4% | 350,768 | -1.4% | 0.00% | 0.0% |
Q4 2022 | $2,628,438 | -26.5% | 355,675 | -1.7% | 0.00% | -33.3% |
Q3 2022 | $3,575,000 | -15.0% | 361,785 | -6.2% | 0.00% | 0.0% |
Q2 2022 | $4,205,000 | -7.2% | 385,718 | -3.7% | 0.00% | 0.0% |
Q1 2022 | $4,530,000 | -31.4% | 400,524 | -4.8% | 0.00% | -25.0% |
Q4 2021 | $6,600,000 | -13.6% | 420,623 | -5.6% | 0.00% | -20.0% |
Q3 2021 | $7,637,000 | -21.2% | 445,556 | -1.2% | 0.01% | -16.7% |
Q2 2021 | $9,697,000 | +43.1% | 450,792 | -0.1% | 0.01% | +20.0% |
Q1 2021 | $6,778,000 | +16.0% | 451,261 | +1.5% | 0.01% | +25.0% |
Q4 2020 | $5,842,000 | +53.3% | 444,621 | +12.7% | 0.00% | +33.3% |
Q3 2020 | $3,812,000 | -18.5% | 394,632 | -3.5% | 0.00% | -25.0% |
Q2 2020 | $4,677,000 | +9.3% | 408,857 | -1.0% | 0.00% | -20.0% |
Q1 2020 | $4,278,000 | -39.3% | 412,975 | -3.8% | 0.01% | -16.7% |
Q4 2019 | $7,043,000 | +26.2% | 429,168 | +2.1% | 0.01% | +20.0% |
Q3 2019 | $5,580,000 | -6.8% | 420,188 | -1.1% | 0.01% | 0.0% |
Q2 2019 | $5,985,000 | -24.5% | 424,779 | -1.5% | 0.01% | -28.6% |
Q1 2019 | $7,931,000 | -30.0% | 431,041 | -0.5% | 0.01% | -41.7% |
Q4 2018 | $11,323,000 | +11.8% | 433,340 | -1.8% | 0.01% | +33.3% |
Q3 2018 | $10,127,000 | +164.5% | 441,249 | +106.3% | 0.01% | +125.0% |
Q3 2017 | $3,829,000 | +10.6% | 213,898 | +0.7% | 0.00% | +33.3% |
Q2 2017 | $3,462,000 | +16.5% | 212,398 | +0.1% | 0.00% | -25.0% |
Q1 2017 | $2,972,000 | -13.5% | 212,275 | -1.4% | 0.00% | 0.0% |
Q4 2016 | $3,434,000 | +0.7% | 215,275 | +5.1% | 0.00% | 0.0% |
Q3 2016 | $3,409,000 | +49.6% | 204,849 | +0.6% | 0.00% | +33.3% |
Q2 2016 | $2,278,000 | +30.7% | 203,600 | -2.4% | 0.00% | 0.0% |
Q1 2016 | $1,743,000 | -10.2% | 208,500 | 0.0% | 0.00% | 0.0% |
Q4 2015 | $1,941,000 | -17.5% | 208,500 | 0.0% | 0.00% | -25.0% |
Q3 2015 | $2,352,000 | -10.2% | 208,500 | +1.1% | 0.00% | 0.0% |
Q2 2015 | $2,618,000 | +39.6% | 206,300 | +2.3% | 0.00% | +33.3% |
Q1 2015 | $1,875,000 | -30.5% | 201,635 | +7.0% | 0.00% | -25.0% |
Q4 2014 | $2,699,000 | +32.0% | 188,500 | -4.3% | 0.00% | +33.3% |
Q3 2014 | $2,045,000 | -37.0% | 197,013 | -1.8% | 0.00% | -40.0% |
Q2 2014 | $3,245,000 | +5.5% | 200,553 | +6.0% | 0.01% | 0.0% |
Q1 2014 | $3,075,000 | +20.8% | 189,200 | -7.8% | 0.01% | 0.0% |
Q4 2013 | $2,546,000 | +100.2% | 205,185 | +76.9% | 0.01% | +66.7% |
Q3 2013 | $1,272,000 | +968.9% | 115,985 | +686.9% | 0.00% | – |
Q2 2013 | $119,000 | – | 14,739 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Profit Investment Management, LLC | 326,997 | $1,412,627 | 1.00% |
Stonepine Capital Management, LLC | 477,903 | $2,064,541 | 0.69% |
Krensavage Asset Management, LLC | 360,429 | $1,557 | 0.57% |
Nantahala Capital Management | 1,000,000 | $4,320,000 | 0.37% |
Monaco Asset Management SAM | 135,000 | $583,200 | 0.17% |
CTC Alternative Strategies, Ltd. | 18,400 | $79,488 | 0.15% |
GSA CAPITAL PARTNERS LLP | 406,019 | $1,754 | 0.15% |
Sio Capital Management, LLC | 97,616 | $421,701 | 0.13% |
HUSSMAN STRATEGIC ADVISORS, INC. | 156,000 | $673,920 | 0.13% |
Virtus ETF Advisers LLC | 48,530 | $209,650 | 0.13% |